.

Make Better Decisions

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
McKesson
Medtronic
Citi
Argus Health
Cantor Fitzgerald
Federal Trade Commission
Mallinckrodt
Harvard Business School
Johnson and Johnson

Generated: November 23, 2017

DrugPatentWatch Database Preview

OSMITROL 5% IN WATER IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

What is the patent landscape for Osmitrol 5% In Water In Plastic Container, and what generic Osmitrol 5% In Water In Plastic Container alternatives are available?

Osmitrol 5% In Water In Plastic Container is a drug marketed by Baxter Hlthcare and is included in one NDA.

The generic ingredient in OSMITROL 5% IN WATER IN PLASTIC CONTAINER is mannitol. There are seventeen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the mannitol profile page.

Summary for OSMITROL 5% IN WATER IN PLASTIC CONTAINER

Pharmacology for OSMITROL 5% IN WATER IN PLASTIC CONTAINER

Drug ClassOsmotic Diuretic
Mechanism of ActionOsmotic Activity
Physiological EffectIncreased Diuresis

Medical Subject Heading (MeSH) Categories for OSMITROL 5% IN WATER IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Baxter Hlthcare
OSMITROL 5% IN WATER IN PLASTIC CONTAINER
mannitol
INJECTABLE;INJECTION013684-005Approved Prior to Jan 1, 1982APRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Cerilliant
Express Scripts
Accenture
Dow
McKinsey
Healthtrust
Queensland Health
Daiichi Sankyo
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot